Insider · CIK 0001553593

Dunne Michael W.

Reports to the SEC for 3 companies · MORRISTOWN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001553593

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-18	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+6,000 sh	$0.37	+$2,191.2	241,001
2025-08-08	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+15K sh	$0.72	+$10.9K	235,001
2024-08-06	ITRMIterum Therapeutics plc · Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+106K sh	—	—	106,247
2024-08-06	ITRMIterum Therapeutics plc · Warrants (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+106K sh	—	—	106,247
2024-08-06	ITRMIterum Therapeutics plc · Subscription Rights (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−212K sh	—	—	0
2024-08-06	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+106K sh	—	—	220,001
2023-12-22	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+25K sh	$1.40	+$35K	113,754
2023-12-18	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+10K sh	$1.84	+$18.4K	88,754
2023-11-22	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+20K sh	$2.03	+$40.7K	78,754
2023-10-01	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,487 sh	—	—	0
2023-10-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+3,487 sh	—	—	58,754
2023-07-01	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,779 sh	—	—	0
2023-07-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+1,779 sh	—	—	55,267
2023-06-15	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	—	—	53,488
2023-06-15	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−15.9K sh	—	—	0
2023-04-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+1,299 sh	—	—	37,635
2023-04-01	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,299 sh	—	—	0
2023-04-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+1,299 sh	—	—	37,636
2023-01-01	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−761 sh	—	—	0
2023-01-01	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+761 sh	—	—	36,337
2022-12-23	ITRMIterum Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+3,487 sh	—	—	3,487
2022-09-25	ITRMIterum Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+1,779 sh	—	—	1,779
2022-09-07	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+10K sh	$2.22	+$22.2K	35,576
2022-06-25	ITRMIterum Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+19.5K sh	—	—	19,488
2022-06-23	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+36.8K sh	—	—	383,647
2022-06-23	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−36.8K sh	—	—	0
2022-06-15	ITRMIterum Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+238K sh	—	—	237,795
2022-03-25	ITRMIterum Therapeutics plc · Restricted Share UnitsA Award	Director	AAward	+11.4K sh	—	—	11,426
2022-03-25	ITRMIterum Therapeutics plc · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−10.5K sh	—	—	0
2022-03-25	ITRMIterum Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+10.5K sh	—	—	346,849
2021-07-25	ITRMIterum Therapeutics plcA Award	Director	AAward	+80K sh	—	—	336,355
2021-06-23	ITRMIterum Therapeutics plc · Restricted Stock UnitsA Award	Director	AAward	+36.8K sh	—	—	36,798
2021-03-25	ITRMIterum Therapeutics plc · Restricted Stock UnitsA Award	Director	AAward	+10.5K sh	—	—	10,494
2021-01-26	ITRMIterum Therapeutics plcS Sale	Director	SSale	−33.1K sh	$1.73	−$57.3K	256,355
2021-01-25	ITRMIterum Therapeutics plcA Award	Director	AAward	+80K sh	—	—	289,498
2020-10-27	ITRMIterum Therapeutics plc · Warrants (right to buy)P Purchase	Director	PPurchase	+46.2K sh	—	—	46,155
2020-10-27	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+61.5K sh	—	—	209,498
2019-02-15	ITRMIterum Therapeutics plc · Stock Option (Right to Buy)A Award	Director	AAward	+85K sh	—	—	85,000
2018-09-04	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+500 sh	$10.00	+$5,000	147,958
2018-08-27	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+500 sh	$10.00	+$5,000	147,458
2018-08-24	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+500 sh	$10.00	+$5,000	146,958
2018-05-30	ITRMIterum Therapeutics plc · Series A Preferred SharesC Conversion	Director	CConversion	−12.7K sh	—	—	0
2018-05-30	ITRMIterum Therapeutics plc · Series B-2 Preferred SharesC Conversion	Director	CConversion	−2,917 sh	—	—	0
2018-05-30	ITRMIterum Therapeutics plc · Series B-1 Preferred SharesC Conversion	Director	CConversion	−4,050 sh	—	—	0
2018-05-30	ITRMIterum Therapeutics plcP Purchase	Director	PPurchase	+2,000 sh	$13.00	+$26K	146,458
2018-05-30	ITRMIterum Therapeutics plcC Conversion	Director	CConversion	+2,917 sh	—	—	144,458
2018-05-30	ITRMIterum Therapeutics plcC Conversion	Director	CConversion	+4,050 sh	—	—	141,541
2018-05-30	ITRMIterum Therapeutics plcC Conversion	Director	CConversion	+12.7K sh	—	—	137,491
2018-05-24	ITRMIterum Therapeutics plc · Stock Option (Right to Buy)A Award	Director	AAward	+79.6K sh	—	—	79,567
2017-05-18	VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	$0.49	+$9,800	75,000

Recent filings

Accepted (ET)
Nov 204
Dunne Michael W.0001193125-25-288848
SEC(opens sec.gov)
Aug 124
Dunne Michael W.0000950170-25-106908
SEC(opens sec.gov)
Aug 124
Dunne Michael W.0000950170-24-095096
SEC(opens sec.gov)
Dec 274
Dunne Michael W.0001209191-23-059750
SEC(opens sec.gov)
Dec 194
Dunne Michael W.0001209191-23-059133
SEC(opens sec.gov)
Nov 274
Dunne Michael W.0001209191-23-056685
SEC(opens sec.gov)
Oct 24
Dunne Michael W.0001209191-23-050911
SEC(opens sec.gov)
Jul 34
Dunne Michael W.0001209191-23-040406
SEC(opens sec.gov)
Jun 154
Dunne Michael W.0001209191-23-037407
SEC(opens sec.gov)
Jun 54/A
Dunne Michael W.0001209191-23-034106
SEC(opens sec.gov)
Apr 34
Dunne Michael W.0001209191-23-022422
SEC(opens sec.gov)
Jan 44
Dunne Michael W.0001209191-23-001287
SEC(opens sec.gov)

Companies

Address

C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR

MORRISTOWN, NJ, 07960